Guangdong Jianke Pharmaceutical Co.
Latest round
- Series C
Last raised
- May 2020
Total raised
- $285M
Investors
- 5
About Guangdong Jianke Pharmaceutical Co.
, Ltd. is a medical technology company that provides Internet chronic disease management services. In June 2022, it established the Chronic Liver Disease Health Management Center. In July 2024, the company was listed on the Hong Kong Stock Exchange. Its stock code is 06086. The company's main product is an online pharmaceutical e-commerce platform. The medical online e-commerce platform sells medicines, health products, weight loss and skin care products, maternal and child products, etc. The company also provides one-on-one health consultation and medication guidance services. The company’s revenue is generated by providing pharmaceutical products and pharmaceutical services. In the future, the company will expand the market and recruit talents.
Who invested in Guangdong Jianke Pharmaceutical Co.
5 investors across 4 rounds
See all investors in Guangdong Jianke Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Guangdong Jianke Pharmaceutical Co.
Who invested in Guangdong Jianke Pharmaceutical Co.?
Guangdong Jianke Pharmaceutical Co. has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guangdong Jianke Pharmaceutical Co. raised?
Guangdong Jianke Pharmaceutical Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Guangdong Jianke Pharmaceutical Co. last raise money?
Guangdong Jianke Pharmaceutical Co.'s most recent round on record is a Series C, in May 2020.
What does Guangdong Jianke Pharmaceutical Co. do?
Guangdong Jianke Pharmaceutical Co. is a internet company.
Where is Guangdong Jianke Pharmaceutical Co. headquartered?
Guangdong Jianke Pharmaceutical Co. is headquartered in Dongguan, China.
Which VCs invest in companies like Guangdong Jianke Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back internet companies at Guangdong Jianke Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing internet startups at Series C
Raising like Guangdong Jianke Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.